{"i": ["ODT to OCT", "ODT", "ODT or OCT formulations", "ODT or OCT .", "olanzapine orodispersible tablet", "OCT formulation", "conventional oral tablet", "glibencl - amide", "fast - dissolving tablet formulation", "valproic acid", "OCT formulation .", "OCT or ODT", "OCT", "non - olanzapine", "ODT or OCT formulation", "olanzapine orodispersible tablet ( ODT ) with oral conventional tablet ( OCT ).", "olanzapine ODT", "cyclos - porine capsules", "fluvoxamine", "diazepam", "olanzapine", "conventional olanzapine tablet", "OCT monotherapy", "OCT to ODT", "ODT or OCT", "diazepam , bromazepam , capto - pril and carbamazapine", "simvastatin", "hydro - chlorothiazide", "conventional tablets and capsules", "ODT formulation"], "o": ["Disease severity", "obesity", "medication adherence", "serious adverse events", "Drug Attitude Inventory ( DAI - 10 ) and Medication Adherence Form ( MAF ) scales ; tolerability and safety by Association for Methodology and Documentation in Psychiatry ( AMDP - 5 ) questionnaire", "hypertriglyceridemia", "visual analogue scale ( VAS )", "VAS subjective appetite assessment , laboratory values , weight and vital sign measures", "Total preference", "weight increase", "Mean weight increase", "psychopathology .", "Safety and tolerability", "Clinical Global Impression of Severity ( CGI - S ) score", "efficacy", "ease of use , taste of the formulation , expectation of better effectiveness and weight change .", "Efficacy ( CGI - S )", "clinical severity status", "MAF and DAI - 10 scores", "difference of weight and BMI", "appetite level", "VAS scale [ appetite scale", "subjective experience", "adverse event ( AE", "Compliance and drug attitude", "psychotic symptoms", "Drug Attitude Inventory DAI - 10 scale", "Beck Depression Inventory", "appetite", "Compliance", "adherent", "adverse event profiles", "Positive and Negative Symptoms Scale ( PANSS ) total score", "DAI - 10", "total number of patients with at least one AE", "appetite changes", "somnolence", "Concomitant medication use", "AE", "AMDP - 5 scale , safety and tolerability", "CGI - S", "mean CGI - S", "CGI - S , compliance , drug attitude , weight", "tablet count", "MAF", "AMDP - 5 scale", "prolactin , liver function , blood biochemistry , whole blood count and ECG", "adverse events", "appendicitis and completed suicide .", "Clinical Global Impression of Severity ( CGI - S ) scale"]}